Great Point Partners I (GPP I) is a fully invested $156 million private equity fund with thirteen platform companies. Great Point is currently investing from GPP II, a follow-on fund that has closed on $215 million in commitments. The fund makes growth recapitalizations and growth equity investments of $7 to $25 million. Most of the companies we invest in are growing and profitable.
GPP invests in a broad range of health care segments including behavioral health, biologics manufacturing, biopharmaceutical supplies, devices/diagnostics, health care services, hospital outsourcing, information technology, medical devices, pharmaceutical infrastructure, and specialty pharmaceuticals.
We use our own equity capital to provide shareholder liquidity in private companies, complete growth recapitalizations, fund growth capital, close fold-in acquisitions, lead management buy-outs, and finance corporate spin-offs.
Although we often contact management teams directly about financing their company’s growth, we strongly encourage executives to contact a Great Point professional directly about a potential investment opportunity.
To identify the Great Point Partners private equity professional best able to add
value to your business, please look at
Our Private Equity Team.